AAAAAA
Results:
1-7
|
Results: 7
Authors:
Tang, CY
Shou, MG
Rushmore, TH
Mei, Q
Sandhu, P
Woolf, EJ
Rose, MJ
Gelmann, A
Greenberg, HE
De Lepeleire, I
Van Hecken, A
De Schepper, PJ
Ebel, DL
Schwartz, JI
Rodrigues, AD
Citation: Cy. Tang et al., In-vitro metabolism of celecoxib, a cyclooxygenase-2 inhibitor, by allelicvariant forms of human liver microsomal cytochrome P4502C9: correlation with CYP2C9 genotype and in-vivo pharmacokinetics, PHARMACOGEN, 11(3), 2001, pp. 223-235
Authors:
Van Hecken, A
Schwartz, JI
Depre, M
De Lepeleire, I
Dallob, A
Tanaka, W
Wynants, K
Buntinx, A
Arnout, J
Wong, PH
Ebel, DL
Gertz, BJ
De Schepper, PJ
Citation: A. Van Hecken et al., Comparative inhibitory activity of rofecoxib, meloxicam, diclofenac, ibuprofen, and naproxen on COX-2 versus COX-1 in healthy volunteers, J CLIN PHAR, 40(10), 2000, pp. 1109-1120
Authors:
Depre, M
Ehrich, E
Van Hecken, A
De Lepeleire, I
Dallob, A
Wong, P
Porras, A
Gertz, BJ
De Schepper, PJ
Citation: M. Depre et al., Pharmacokinetics, COX-2 specificity, and tolerability of supratherapeutic doses of rofecoxib in humans, EUR J CL PH, 56(2), 2000, pp. 167-174
Authors:
Dallob, A
De Lepeleire, I
Van Hecken, A
Porras, A
Depre, M
Mukhopadhyay, S
Flynn, M
Wildonger, L
Gottesdiener, K
Tanaka, W
De Schepper, P
Citation: A. Dallob et al., Ex vivo assays demonstrate potency and selectivity of the COX-2 inhibitor DFP after single dose administration, INFLAMM RES, 48, 1999, pp. S130-S131
Authors:
Depre, M
Van Hecken, A
Verbesselt, R
Wynants, K
De Lepeleire, I
Freeman, A
Holland, S
Shahane, A
Gertz, B
De Schepper, PJ
Citation: M. Depre et al., Effect of multiple doses of montelukast, a cysLT(1) receptor antagonist, on digoxin pharmacokinetics in healthy volunteers, J CLIN PHAR, 39(9), 1999, pp. 941-944
Effect of montelukast on the pharmacokinetics and pharmacodynamics of warfarin in healthy volunteers
Authors:
Van Hecken, A
Depre, M
Verbesselt, R
Wynants, K
De Lepeleire, I
Arnout, J
Wong, PH
Freeman, A
Holland, S
Gertz, B
De Schepper, PJ
Citation: A. Van Hecken et al., Effect of montelukast on the pharmacokinetics and pharmacodynamics of warfarin in healthy volunteers, J CLIN PHAR, 39(5), 1999, pp. 495-500
Authors:
Ehrich, EW
Dallob, A
De Lepeleire, I
Van Hecken, A
Riendeau, D
Yuan, WY
Porras, A
Wittreich, J
Seibold, JR
De Schepper, P
Mehlisch, DR
Gertz, BJ
Citation: Ew. Ehrich et al., Characterization of rofecoxib as a cyclooxygenase-2 isoform inhibitor and demonstration of analgesia in the dental pain model, CLIN PHARM, 65(3), 1999, pp. 336-347
Risultati:
1-7
|